1Rifai N, Joubran R. Yu H, et al. Imflamatory markers in men with angiographically documented, coronary heart disease[J]. Clin Chem, 1999,45:1967-1973.
2Grayston JT. Antibiotic treatment trails for secondary prevention of coronary artery disease events[J]. Circulation,1999,99:1538--39.
3Saikku P. Leinonem M. Mattilak, et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction[J]. Lancet,1988,2:983-986.
4Anderson JL. Mouhlestein JB. Carlquist J. et al. Randomized secondary prevention trail of azithromycin in patients with coronary artery disease and serological evidence for chlamydia pneumoniae infection[J], circulation,1999,99:1540-1547.
5Liuzzo G, Biasucci LM. Gallimore JR, The prognotic value of C-reactive protein and serum amyloid A protein in severe unstable agnina, N Engl J Med,1994,331:471-424.
6Marrow DA. Rifai N, Antman EM, et al. C-reactive protein is a potent predictar of mortality in acute coranary syndromes [J]. A TIMI-Ⅱ a sub study[J]. J Am Coll Cardiol,1998,31:1460-1465.
7Marrow DA, Rifai N. Antman EM, et al. Serum amyloid A protein predicts early mortality in acute coronary syndromes [J].ATIMI Ⅱ a Sub study(Abstract)[J]. Circulation,1998,98(Suppl):1-493.
8Biasucci LM, Vitelli A. Luizzo G, et al. Elevated levels of interleukin-6 in unstable angina[J]. Circulation,1996,94:874-877.
9Clinton SK. Under Wood R. Hayes I, et al. Macrqohage clony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis[J]. Am J Path,1992,140:301-306.
10Gurbel PA, Serebruany VL. Odhesion molecules, platelets activation, and cardiovascular risk[J]. Am Heart J,2002,143:196- 198.
